Zabaleta-Apiroz, A. (., Puig, N. (., Cedena, M. (. T., Oliver-Calde, A. (., Perez, J. (. J., Moreno-Parado, C. (., . . . Puertas, B. (. (2024). Clinical significance of complete remission and measurable residual disease in relapsed/refractory multiple myeloma patients treated with T-cell redirecting immunotherapy.
Chicago Style CitationZabaleta-Apiroz, A. (Aintzane)|||/items/b22de5a6-cfd3-41a9-8d6a-004c620cc6a5, et al. Clinical Significance of Complete Remission and Measurable Residual Disease in Relapsed/refractory Multiple Myeloma Patients Treated With T-cell Redirecting Immunotherapy. 2024.
MLA CitationZabaleta-Apiroz, A. (Aintzane)|||/items/b22de5a6-cfd3-41a9-8d6a-004c620cc6a5, et al. Clinical Significance of Complete Remission and Measurable Residual Disease in Relapsed/refractory Multiple Myeloma Patients Treated With T-cell Redirecting Immunotherapy. 2024.